Directory
>
Andreas Harsch
Andreas Harsch
VP Preclinical Development | Kymera Therapeutics
Wellesley, Massachusetts, United States
Andreas Harsch
Summary
Andreas Harsch is a seasoned executive in the biotechnology and pharmaceutical sectors, currently serving as the VP of Preclinical Development at Kymera Therapeutics. With a robust background in drug metabolism and pharmacokinetics, he has held leadership roles at prominent companies like Novartis and AstraZeneca, where he has been instrumental in advancing oncology research. Andreas has a Ph.D. in Organic Chemistry from the University of Cincinnati and extensive experience in analytical chemistry. His career reflects a strong commitment to innovation in drug development, particularly in the areas of biomarkers and clinical development. His diverse experience spans from senior scientist roles to executive leadership, showcasing his ability to lead teams and drive change in complex environments. Outside of his professional life, Andreas is likely to be passionate about mentoring the next generation of scientists and fostering collaborative research efforts.
Andreas Harsch
Work Experience
VP Preclinical Development at
Kymera Therapeutics
November 2022 - Present
Executive Director, Head of DMPK & Toxicology Lead at
Frontier Medicines
November 2021 - November 2022
Director at
Novartis
June 2014 - October 2021
Associate Director at
AstraZeneca
October 2011 - May 2014
Associate Director/Sr. Investigator DMPK at
Merck
December 2007 - September 2011
Senior Research Fellow at
Merck
August 2004 - November 2007
Senior Scientist II at
AbbVie
March 2001 - August 2004
Senior Scientist I at
BASF SE
December 1999 - February 2001
Andreas Harsch
Education
Northeastern University, Post-Doc & Staff Scientist
January 1996 - January 1999
University of Cincinnati, Ph.D.
January 1991 - January 1996
University of Stuttgart, Vordiplom
January 1987 - January 1991
Frequently Asked Questions about Andreas Harsch
What is Andreas Harsch email address?
Andreas Harsch's primary email address is *******@kymeratx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Andreas Harsch work for?
Andreas Harsch is a VP Preclinical Development at Kymera Therapeutics, a company specializing in Commercial physical research.
Where Andreas Harsch graduated from?
Andreas Harsch holds a degree in Analytical Chemistry from Northeastern University.
How can I directly contact Andreas Harsch?
To contact Andreas Harsch directly, you can use the email address *******@kymeratx.com. Complete contact information is available upon registration with Muraena.
Who is Andreas Harsch?
Andreas Harsch is a seasoned executive in the biotechnology and pharmaceutical sectors, currently serving as the VP of Preclinical Development at Kymera Therapeutics. With a robust background in drug metabolism and pharmacokinetics, he has held leadership roles at prominent companies like Novartis and AstraZeneca, where he has been instrumental in advancing oncology research. Andreas has a Ph.D. in Organic Chemistry from the University of Cincinnati and extensive experience in analytical chemistry. His career reflects a strong commitment to innovation in drug development, particularly in the areas of biomarkers and clinical development. His diverse experience spans from senior scientist roles to executive leadership, showcasing his ability to lead teams and drive change in complex environments. Outside of his professional life, Andreas is likely to be passionate about mentoring the next generation of scientists and fostering collaborative research efforts.
Andreas`s contact details
*******@kymeratx.com
**************@novartis.com
Colleagues
Consultant
Executive Director
Chief Financial Officer
Vice President of Finance
Executive Director, Platform Biology
Executive Director, Clinical Data Management
Executive Business Partner to the CEO
Executive Director, Biological Sciences
Founder, President and Chief Executive Officer
Executive Director, Immunology